{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-9840", "postId": 9840, "name": "FMC Corporation", "description": "Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in FMC between February 4, 2026 and October 14, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FMC Corporation (\u201cFMC\u201d or the \u201cCompany\u201d) (NYSE: FMC) and reminds investors of the January 19, 2027 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of FMC’s distributor-inventory problem, including the extent to which elevated-priced inventory held by distributors was difficult to sell thereby impairing replenishment orders across FMC’s portfolio and threatening the Company’s ability to generate new sales, revenue, EBITDA and cash flow. Lead Plaintiff Deadline: January 19, 2027 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Or submit your information below to learn about your rights.", "identifier": "FMC", "legal": { "court": "Eastern District of Pennsylvania", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "02/04/2026", "end": "10/14/2026" }, "leadPlaintiffDeadline": "01/19/2027", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/fmc-corporation/", "canonicalUrl": "https://faruqilaw.com/case/fmc-corporation/", "datePublished": "2026-11-19T21:23:30+00:00", "dateModified": "2026-11-19T21:23:30+00:00", "associatedOrganization": { "@id": "case-9840-org" }, "legalService": { "@id": "case-9840-legalservice" }, "hasPart": [ { "@id": "case-9840-faq" }, { "@id": "case-9840-press-list" } ], "legalRepresentation": [ { "@id": "case-9840-attorney-516" }, { "@id": "case-9840-attorney-506" } ] }, { "@type": "Organization", "@id": "case-9840-org", "name": "FMC Corporation", "identifier": "FMC", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://www.fmc.com" }, { "@type": "LegalService", "@id": "case-9840-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-9840-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-9840-legalservice" } }, { "@type": "Person", "@id": "case-9840-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-9840-legalservice" } }, { "@type": "FAQPage", "@id": "case-9840-faq", "mainEntity": [ { "@type": "Question", "name": "What is the FMC Corporation securities class action lawsuit about?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges that FMC Corporation made materially false and misleading statements to investors while concealing the true extent of a distributor-inventory problem. Specifically, the complaint alleges that elevated-priced inventory held by distributors was difficult to sell, allegedly impairing replenishment orders across FMC's portfolio and threatening the company's ability to generate sales, revenue, EBITDA, and cash flow." } }, { "@type": "Question", "name": "What is the class period for the FMC securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The class period covers investors who purchased or acquired FMC Corporation securities between February 4, 2026 and October 14, 2026. Investors who transacted in FMC stock during this window may be eligible to participate in the litigation." } }, { "@type": "Question", "name": "What is the deadline to file a lead plaintiff motion in the FMC class action?", "acceptedAnswer": { "@type": "Answer", "text": "The deadline to apply to serve as lead plaintiff in the FMC securities class action is January 19, 2027. Investors who wish to take an active role in directing the litigation must submit their motion to the court by this date." } }, { "@type": "Question", "name": "Where is the FMC Corporation securities class action being heard?", "acceptedAnswer": { "@type": "Answer", "text": "The case has been filed in the United States District Court for the Eastern District of Pennsylvania. Investors seeking to follow the case can monitor filings through that court's public records system." } }, { "@type": "Question", "name": "What did FMC allegedly misrepresent to investors?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges that FMC defendants provided overwhelmingly positive statements to investors while concealing material adverse facts about the company's distributor-inventory problem. The complaint alleges that FMC failed to disclose that elevated-priced distributor inventory was difficult to sell, which allegedly threatened the company's ability to generate new sales, revenue, EBITDA, and cash flow." } }, { "@type": "Question", "name": "How did FMC's distributor inventory problem allegedly affect the company?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges that distributors were holding elevated-priced FMC inventory that was difficult to sell, which in turn allegedly impaired replenishment orders across FMC's product portfolio. This situation allegedly posed a threat to FMC's ability to generate new sales and meet its financial projections for revenue, EBITDA, and cash flow." } }, { "@type": "Question", "name": "Who can join the FMC Corporation securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased or acquired FMC Corporation (NYSE: FMC) securities during the class period of February 4, 2026 through October 14, 2026 may be eligible to participate. Affected investors should consult with securities counsel to evaluate their potential claims and options." } }, { "@type": "Question", "name": "Do I need to be lead plaintiff to recover in the FMC securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "No, class members are not required to serve as lead plaintiff in order to potentially recover damages in the FMC securities class action. The lead plaintiff role carries additional responsibilities, including directing the litigation on behalf of the class, and must be applied for by the January 19, 2027 deadline." } } ] }, { "@type": "NewsArticle", "@id": "case-9840-press-1", "headline": "FMC downgraded at Jefferies as 'visibility deteriorates, again' with guidance cut", "url": "https://seekingalpha.com/news/4653967-fmc-downgraded-at-jefferies-as-visibility-deteriorates-again-with-guidance-cut", "datePublished": "2026-10-16" }, { "@type": "NewsArticle", "@id": "case-9840-press-2", "headline": "FMC Corp. to explore strategic options, including possible sale", "url": "https://www.bloomberg.com/news/articles/2026-10-15/fmc-plunges-as-weak-demand-forces-pricing-structure-overhaul", "datePublished": "2026-10-15" }, { "@type": "NewsArticle", "@id": "case-9840-press-3", "headline": "FMC plunges 43% after guiding Q3 revenue far below expectations on weak demand, price cuts", "url": "https://seekingalpha.com/news/4653371-fmc-plunges-43-after-guiding-q3-revenue-far-below-expectations-on-weak-demand-price-cuts", "datePublished": "2026-10-15" }, { "@type": "NewsArticle", "@id": "case-9840-press-4", "headline": "FMC Stock Plummets 38% on Horrendous Guidance", "url": "https://www.barrons.com/articles/fmc-stock-plummets-weak-guidance-15579e06", "datePublished": "2026-10-15" }, { "@type": "NewsArticle", "@id": "case-9840-press-5", "headline": "FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues", "url": "https://www.investing.com/news/stock-market-news/fmc-tumbles-35-after-slashing-q3-outlook-over-weak-demand-and-inventory-issues-4951410", "datePublished": "2026-10-15" }, { "@type": "NewsArticle", "@id": "case-9840-press-6", "headline": "FMC cuts Q3 outlook, takes $625M-$675M in charges", "url": "https://www.investing.com/news/company-news/fmc-cuts-q3-outlook-takes-625m675m-in-charges-93CH-4951403", "datePublished": "2026-10-15" }, { "@type": "NewsArticle", "@id": "case-9840-press-7", "headline": "Crop Chemical Firm FMC to Explore Options Including Sale (3)", "url": "https://news.bloomberglaw.com/mergers-and-acquisitions/crop-chemical-firm-fmc-to-explore-options-including-sale-1", "datePublished": "2026-02-05" }, { "@type": "NewsArticle", "@id": "case-9840-press-8", "headline": "Why FMC Corporation Plunged Today", "url": "https://www.fool.com/investing/2026/02/05/why-fmc-corporation-plunged-today/", "datePublished": "2026-02-05" }, { "@type": "NewsArticle", "@id": "case-9840-press-9", "headline": "FMC Corp. to explore strategic options, including possible sale", "url": "https://seekingalpha.com/news/4547556-fmc-corp-to-explore-strategic-options-including-possible-sale", "datePublished": "2026-02-04" }, { "@type": "ItemList", "@id": "case-9840-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-9840-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-9840-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-9840-press-3" } }, { "@type": "ListItem", "position": 4, "item": { "@id": "case-9840-press-4" } }, { "@type": "ListItem", "position": 5, "item": { "@id": "case-9840-press-5" } }, { "@type": "ListItem", "position": 6, "item": { "@id": "case-9840-press-6" } }, { "@type": "ListItem", "position": 7, "item": { "@id": "case-9840-press-7" } }, { "@type": "ListItem", "position": 8, "item": { "@id": "case-9840-press-8" } }, { "@type": "ListItem", "position": 9, "item": { "@id": "case-9840-press-9" } } ] } ] }

FMC Corporation

FMC Corporation

Join Action
Case Details
Ticker FMC
Class Period 02/04/2026 - 10/14/2026
Lead Plaintiff Deadline 01/19/2027
Days Left to Seek Lead Plaintiff
61

If you are a FMC Corporation investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in FMC between February 4, 2026 and October 14, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) and reminds investors of the January 19, 2027 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of FMC’s distributor-inventory problem, including the extent to which elevated-priced inventory held by distributors was difficult to sell thereby impairing replenishment orders across FMC’s portfolio and threatening the Company’s ability to generate new sales, revenue, EBITDA and cash flow.

Lead Plaintiff Deadline: January 19, 2027

Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Or submit your information below to learn about your rights.

Join Action
FMC Corporation
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771